Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion 
Barclays Downgrades Siemens Energy as Valuation Seen Near Peak 
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia 
TetherMax Rebranding Highlights Official Exchange Partnerships and Transparent Operations 
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share 
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge 
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement 
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings 
SpaceX Stock Draws Bullish Wall Street Coverage Ahead of Nasdaq-100 Inclusion 
Zhipu AI Stock Jumps on Report of Custom AI Chip Development Plans 
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow 
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates 
Lockheed Martin, Rheinmetall Plan First ATACMS Missile Production in Germany 
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate 
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns 
China 618 Smartphone Sales Drop 13% as Higher Prices Hurt Demand, Huawei Gains Market Share 
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy 
 - EconoTimes)
Dublin, May 08, 2018 -- The "Stem Cells in Drug Discovery & Toxicity Screening 2018" conference has been added to ResearchAndMarkets.com's offering.
Stem Cells in Drug Discovery, and Toxicity Screening 2018 brings together researchers from around the world focusing on the emerging technologies and applications in cellular analysis.
Hear from and network with researchers who are currently screening for efficacy and toxicity using iPS cell lines, and those responsible for developing the techniques and technologies. There will also be discussions on industry and regulatory developments that are shaping the future of stem cell usage in drug discovery.
Key Opinion Leaders from around the World are Participating at this Conference allowing Maximal Information Exchange and Unparalleled Networking Opportunities.
Agenda:
- 3D-Cell Culture Based Models
- Technologies in 3D-Cell Culture
- iPSC-derived Cells for Toxicity Testing & Screening
- Screening Technologies, Instrumentation and Reagents
- Stem Cells in Drug Discovery and Development
- Use of Microfluidics Organs-on-Chips for Toxicity Screening
Keynote Speakers
Norio Nakatsuji
Chief Advisor, Stem Cell & Device Laboratory, Inc. (SCAD); Professor Emeritus, Kyoto University
Mark Bradley
Professor, Schools of Chemistry and Medicine, University of Edinburgh
James Hickman
Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos
Gary Gintant
Research Fellow, Abbvie
Confirmed Speakers to Date
Ulrich Broeckel
Professor of Pediatrics, Medicine and Physiology - Chief, Section of Genomic Pediatrics, Medical College of Wisconsin
Guohao Dai
Associate Professor, Department of Bioengineering, Northeastern University
Toshihiko Ezashi
Research Associate Professor, The University of Missouri
Kennedy Okeyo
Senior Lecturer, Institute for Frontier Life and Medical Sciences, Kyoto University
Terry Riss
Global Strategic Marketing Manager Cell Health, Promega Corporation
Daniele Zink
Principal Research Scientist and Team Leader, Institute of Bioengineering and Nanotechology, Agency for Science Technology and Research (A*STAR)
For more information about this conference visit https://www.researchandmarkets.com/research/ndptbs/stem_cells_in?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery, Drug Abuse Screening, Stem Cells
